Inactive Instrument

Stemcell United Limited Share Price Australian S.E.

Equities

BP8

AU000000SCU9

Biotechnology & Medical Research

Financials

Sales 2022 14.35M 9.42M 786M Sales 2023 339 222.48 18.56K Capitalization 3.85M 2.53M 211M
Net income 2022 -3M -1.97M -164M Net income 2023 -4M -2.63M -219M EV / Sales 2022 1.07 x
Net Debt 2022 627K 411K 34.32M Net cash position 2023 511K 335K 27.98M EV / Sales 2023 9,862 x
P/E ratio 2022
-3.98 x
P/E ratio 2023
-0.72 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 35.24%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 30/23/30
Corporate Secretary - 11/04
Members of the board TitleAgeSince
Director/Board Member - 21/21/21
Chairman 63 31/20/31
Director/Board Member - 27/19/27
More insiders
BPH Global Ltd is a plant-focused biotechnology company. The Company is focused on producing foods and products that deliver Traditional Chinese Medicine-based health outcomes. It focuses on the research and development, production and commercialization of plant-based products, including seaweed and sea plants to produce sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients (including cannabidiol (CBD) extracted from Hemp) for utilization in the food, nutrition, healthcare, cosmetics, and personal care industries. Its principal business focus is on Singapore, Australia, Southeast Asia, and Chinese markets. The Company produces its products through various plants, which include Caulerpa lentillifera, Dendrobium officinale, Resina and Cannabis sativa. It is also into the sales and distribution of bird's nest products in China. Its subsidiaries include Stemcell United Pte Ltd, Stemcell Essential Pte Ltd, and SCU Southeast Asia Sdn Bhd, SCU (HK) Ltd.
More about the company